Valion Bio, Inc. Shares Repurchased
Valion Bio, Inc. (VBIO) had Shares Repurchased of 938 shares as of 2022-04-01, per its 10-K filed 2024-03-25.
Discontinued
us-gaap:StockRepurchasedDuringPeriodShares · last filed 2024-03-25
- 2022-04-01: Stock Repurchased During Period, Shares 938.00 shares; Stock Repurchased During Period, Shares as first filed 93.75K shares.
| Period end | Stock Repurchased During Period, Shares | Stock Repurchased During Period, Shares as first filed |
|---|---|---|
| 2022-04-01 | 938.00 shares 10-K · filed 2024-03-25 | 93.75K shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |